Gradient Health Closes $2.75 Million Round for Imaging Library

Gradient Health, a medical AI data-sharing company, has closed a $2.75 million funding round led by ReMY Investors & Consultants. This investment will enable the company to continue assembling the annotated medical imaging library into a unified platform.

Joining REMI in this round are new investors Boro Capital, Supernode Ventures, Maidmountain Ventures, The Triangle Twiner Fund, David Golan and Silicon Valley Social Venture Fund (SV2), as well as existing investors VentureSouth and Wavemaker Three-Sixty Health Happened.

With the increasing use of artificial intelligence in healthcare, access to high-quality and diverse medical imaging data is critical for the development of innovative and robust solutions. Gradient Health’s groundbreaking approach addresses this critical need by providing a vast collection of annotated medical images in a single, secure repository. By developing and curating this comprehensive library, the platform will empower researchers to unlock new insights and reduce bias, promoting progress in diagnosis and treatment.

Josh Miller, CEO of Gradient Health, said: “We are thrilled to have secured $2.75 million in funding, which will accelerate our mission to transform medical AI data sharing. This investment will allow us to continue to assemble the world’s largest and most comprehensive collection of annotated medical imaging data. With this dataset, we aim to revolutionize medical research and ultimately improve patient outcomes.

The company’s platform offers a range of powerful features designed to facilitate tailored research and seamless collaboration. It employs state-of-the-art security measures to ensure the confidentiality and compliance of sensitive patient information. Additionally, it provides advanced tools for developers including machine-learning-ready formatting, the ability to search by disease, and imaging modalities.

Shana Barghouti, co-CIO of Remi Investors & Consultants, who led the round, commented: “We are excited by Gradient’s vision of creating the data layer that will underpin all future medical AI. We are impressed with the team, the approach and the progress the team has already made. Gradient Health is building capabilities that will allow for rapid and game-changing advancements in the medical and pharmaceutical industries.

Jay Goss, general partner at investor wavemaker Three-Sixty Health, which invested in Gradient Health in a previous round, said: “As healthcare navigates its way with the world of artificial intelligence, which is still in its early stages, A key unlock comes with access to clinical data – particularly imaging – so that models can be trained responsibly. Gradient has established itself as a leader in this, ensuring that an efficient marketplace exists between algorithm makers and the healthcare industry. We couldn’t be more excited to join this exciting company and amazing team.”